Tamoxifen for hepatocellular carcinoma
Naing, Cho, Ni, Han, Aung, Htar Htar, and Mak, Joon Wah (2021) Tamoxifen for hepatocellular carcinoma. Cochrane Database of Systematic Reviews, 2021 (5). CD014869.
![[img]](https://researchonline.jcu.edu.au/style/images/fileicons/application_pdf.png) |
PDF (Published Version)
- Published Version
Restricted to Repository staff only |
View at Publisher Website: https://doi.org/10.1002/14651858.CD01486...
2
448
Abstract
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of tamoxifen in people with hepatocellular carcinoma, irrespective of sex, administered dose, type of formulation, and duration of treatment.
| Item ID: | 70394 |
|---|---|
| Item Type: | Article (Scholarly Work) |
| ISSN: | 1469-493X |
| Copyright Information: | Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. |
| Date Deposited: | 30 May 2022 00:35 |
| Downloads: |
Total: 448 |
| More Statistics |
Actions (Repository Staff Only)
 |
Item Control Page |